TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021
PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer.
Yoon-Koo Kang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
248 papers cite itlatest 60 shown
this paperpooled ittrialcites it